Immuneering Corporation (IMRX) Gross margin 2020–2022
Immuneering Corporation (IMRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
50.1%FY2022 · since FY2020: 44.6% → 50.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 50.1% | +5.5 pp |
| FY2021 | 44.6% | -0.0 pp |
| FY2020 | 44.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice